TipRanks
Elevance Health (MX:ELV)
:ELV
Mexico Market
ELV
Elevance Health
RESEARCH TOOLSreports

Elevance Health (ELV) Ratios

0 Followers

Elevance Health Ratios

MX:ELV's free cash flow for Q3 2026 was $0.16. For the 2026 fiscal year, MX:ELV's free cash flow was decreased by $ and operating cash flow was $0.04. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.47 1.24 1.10 0.00 0.00
Quick Ratio
 1.47 1.24 1.10 0.00 0.00
Cash Ratio
 0.22 0.48 0.43 0.00 0.00
Solvency Ratio
 0.08 0.09 0.10 0.11 0.11
Operating Cash Flow Ratio
 0.16 0.21 0.30 0.00 0.00
Short-Term Operating Cash Flow Coverage
 20.26 3.11 2.68 4.30 4.76
Net Current Asset Value
$ -14.48B$ -52.74B$ -54.12B$ -69.52B$ -66.42B
Leverage Ratios
Debt-to-Assets Ratio
 0.24 0.27 0.28 0.23 0.23
Debt-to-Equity Ratio
 0.69 0.76 0.79 0.64 0.67
Debt-to-Capital Ratio
 0.41 0.43 0.44 0.39 0.40
Long-Term Debt-to-Capital Ratio
 0.40 0.42 0.42 0.37 0.38
Financial Leverage Ratio
 2.86 2.77 2.83 2.77 2.84
Debt Service Coverage Ratio
 5.11 3.09 2.55 3.02 3.22
Interest Coverage Ratio
 6.56 5.79 7.50 7.49 8.93
Debt to Market Cap
 0.34 0.42 0.37 0.23 0.20
Interest Debt Per Share
 146.57 156.16 145.52 112.20 104.02
Net Debt to EBITDA
 2.30 2.46 2.33 1.77 1.65
Profitability Margins
Gross Profit Margin
36.55%25.56%27.85%100.00%100.00%
EBIT Margin
3.66%4.07%5.14%5.10%5.40%
EBITDA Margin
4.40%4.85%5.93%6.12%6.47%
Operating Profit Margin
3.69%4.07%5.03%4.50%4.85%
Pretax Profit Margin
3.10%3.37%4.47%4.50%4.85%
Net Profit Margin
2.55%2.84%3.38%3.49%3.76%
Continuous Operations Profit Margin
2.53%2.84%3.38%3.50%3.76%
Net Income Per EBT
82.22%84.38%75.66%77.60%77.55%
EBT Per EBIT
83.81%82.72%88.93%100.00%100.00%
Return on Assets (ROA)
4.02%4.66%5.12%5.50%5.74%
Return on Equity (ROE)
11.59%12.90%14.47%15.23%16.26%
Return on Capital Employed (ROCE)
9.19%7.99%9.12%7.08%7.40%
Return on Invested Capital (ROIC)
7.47%6.65%6.74%319.69%333.60%
Return on Tangible Assets
5.80%6.91%7.82%8.16%8.66%
Earnings Yield
5.62%7.28%6.96%5.45%4.79%
Efficiency Ratios
Receivables Turnover
 8.21 13.07 13.54 9.59 9.76
Payables Turnover
 15.40 8.68 8.10 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 43.75 38.81 33.88 39.31 36.28
Asset Turnover
 1.58 1.64 1.51 1.57 1.52
Working Capital Turnover Ratio
 7.17 59.52 260.59 0.00 0.00
Cash Conversion Cycle
 20.74 -14.14 -18.10 38.06 37.40
Days of Sales Outstanding
 44.44 27.93 26.95 38.06 37.40
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 23.70 42.07 45.05 0.00 0.00
Operating Cycle
 44.44 27.93 26.95 38.06 37.40
Cash Flow Ratios
Operating Cash Flow Per Share
 34.91 19.34 24.94 34.59 35.00
Free Cash Flow Per Share
 29.94 14.31 19.55 29.03 30.20
CapEx Per Share
 4.97 5.03 5.39 5.56 4.80
Free Cash Flow to Operating Cash Flow
 0.86 0.74 0.78 0.84 0.86
Dividend Paid and CapEx Coverage Ratio
 2.94 1.62 2.10 3.00 3.53
Capital Expenditure Coverage Ratio
 7.02 3.84 4.62 6.22 7.29
Operating Cash Flow Coverage Ratio
 0.25 0.13 0.18 0.32 0.35
Operating Cash Flow to Sales Ratio
 0.04 0.02 0.03 0.05 0.05
Free Cash Flow Yield
7.15%4.08%5.30%6.16%5.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 17.89 13.92 14.29 18.36 20.89
Price-to-Sales (P/S) Ratio
 0.45 0.39 0.49 0.64 0.79
Price-to-Book (P/B) Ratio
 2.05 1.77 2.08 2.80 3.40
Price-to-Free Cash Flow (P/FCF) Ratio
 13.99 24.50 18.87 16.25 16.99
Price-to-Operating Cash Flow Ratio
 12.03 18.12 14.79 13.63 14.66
Price-to-Earnings Growth (PEG) Ratio
 -4.22 -5.70 8.44 5.50 -7.64
Enterprise Value Multiple
 12.56 10.51 10.52 12.25 13.81
Enterprise Value
 111.51B 101.50B 110.32B 128.50B 139.84B
EV to EBITDA
 12.56 10.51 10.52 12.25 13.81
EV to Sales
 0.55 0.51 0.62 0.75 0.89
EV to Free Cash Flow
 17.12 31.98 24.23 18.99 19.30
EV to Operating Cash Flow
 14.68 23.66 18.99 15.94 16.65
Tangible Book Value Per Share
 25.62 20.21 4.53 16.37 6.80
Shareholders’ Equity Per Share
 205.34 197.84 177.42 168.64 151.01
Tax and Other Ratios
Effective Tax Rate
 0.18 0.16 0.24 0.22 0.23
Revenue Per Share
 927.53 897.77 759.28 735.14 652.48
Net Income Per Share
 23.62 25.53 25.68 25.69 24.56
Tax Burden
 0.82 0.84 0.76 0.78 0.78
Interest Burden
 0.85 0.83 0.87 0.88 0.90
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.06 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 1.49 0.76 0.97 1.35 1.40
Currency in USD